Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Gilead Sciences, Inc. (GILD)

« Back to company index

GILD Chatter Timeline

Stock Ticker for GILD

Most Active Tweeters for GILD

UserTweets
@bs_marker 32
@gilded_games 16
@MarcJacksonLA 12
@StckPro 10
@TradeWithAlerts 9

Recent Tweets for GILD

bs_marker @bs_marker
Stock: $GILD - *** REALTIME TREND *** SELL BUY = 45.27% SELL = 54.73% Try now the Best Pivot Point Calculator!!… https://t.co/wybPlpmU5g
5:01am
OptionsMaxPain @OptionsMaxPain
#Options #maxpain chart for $GILD. Free options app https://t.co/EQL2cBOq5n https://t.co/sAO8Q8i2C7
3:01am
OptionsProOI @OptionsProOI
$GILD #Options OI chart. Free stock apps https://t.co/7Rm8mjs1IV https://t.co/a4beaypaJz
3:01am
OptionsProVol @OptionsProVol
$GILD #Options volume chart in animation. Free super stocks app https://t.co/RawBHHJxMV https://t.co/QLfIycfvsc
3:01am
therealmrmomo @therealmrmomo
@JohnCendpts $gild in a purgatory period, very reminiscent of $msft between 2002-2015.
3:01am
SweepCastApp @SweepCastApp
$GILD Gilead Sciences Option Alert: Feb 18 $72.5 Calls Sweep (22) near the Bid: 227 vs 5343 OI; Earnings 2/3 After… https://t.co/nbuJEAhCdC
3:01am
realmaciej @realmaciej
RT @jq1234t: $GILD CD47: FDA put partial clinical hold on studies evaluating combination of magrolimab plus azacitidine including ENHANCE d…
3:01am
realmaciej @realmaciej
RT @Sanctuary_Bio: It is staggering how much $GILD has spent on oncology and how little they have to show for it. Lot of pressure on TROPiC…
3:01am
Bionavgator @Bionavgator
@Kevin_M_Biotech @Biohazard3737 Trodelvy is next $gild
2:01am
ShehlaShakoor @ShehlaShakoor
RT @JohnCendpts: BREAKING: In a setback, FDA orders Gilead to hit the brakes on their late-stage, $5B cancer play $GILD https://t.co/SdCvlT…
2:01am
ej23ny @ej23ny
@JohnCendpts Hopefully @GileadSciences $GILD Daniel O'Day realizes that the best route is Combination of CD47 wit… https://t.co/slwjZ17cS5
2:01am
Kevin_M_Biotech @Kevin_M_Biotech
@Biohazard3737 I have been saying this today - $gild curse is real… is $rcus next?
2:01am
JohnCendpts @JohnCendpts
BREAKING: In a setback, FDA orders Gilead to hit the brakes on their late-stage, $5B cancer play $GILD https://t.co/SdCvlTbRmp
2:01am
JoshAnd20147162 @JoshAnd20147162
Talking with #gilead $gild and Viiv regarding their HIV Mab program, they are both interested in Enzolytics, Enzoly… https://t.co/scFogX2QQj
1:01am
SVENNIECO @SVENNIECO
FDA issues partial hold affecting Gilead's anti-CD47 antibody magrolimab $GILD https://t.co/uqJBaXdeLd
1:01am
SVENNIECO @SVENNIECO
FDA issues partial hold affecting Gilead’s anti-CD47 antibody magrolimab $GILD https://t.co/kqaoF3HSyF
1:01am
tstamm7002 @tstamm7002
$GILD another faqing disaster
1:01am
zbiotech @zbiotech
RT @adamfeuerstein: $GILD - FDA places partial clinical hold on studies combining magrolimab (its anti-CD47 antibody) with azicitadine, due…
1:01am
fwpharma @fwpharma
FDA issues partial hold affecting Gilead's anti-CD47 antibody magrolimab $GILD https://t.co/kYbN8jlDIt
1:01am
SnupSnus @SnupSnus
don't really know why the ? is smiling... $GILD shareholders sure ain't!... More like ? thinking about O`Day gettin… https://t.co/ibH2bD3GWF
1:01am
lblegend33 @lblegend33
@Sanctuary_Bio I’ve said it over and over $gild Mgmt has been awful.
1:01am
Sanctuary_Bio @Sanctuary_Bio
It is staggering how much $GILD has spent on oncology and how little they have to show for it. Lot of pressure on T… https://t.co/oTJCq9Nw3X
1:01am
MauriceOnTW @MauriceOnTW
@bradloncar Didn't $gild buy near the peak of the cd47 frenzy? Not familiar with all the deals he's done but severa… https://t.co/SZM74cXULN
1:01am
bradloncar @bradloncar
I’m just now seeing the $GILD CD47 news. When it rains it pours.
1:01am
BRAINCURES @BRAINCURES
RT @JacobPlieth: Did $GILD drop the ball on momelotinib? Did Nick Glover perform a biotech miracle? My take on today's $SRRA data, via @eva…
12:01am
Kevin_M_Biotech @Kevin_M_Biotech
@adamfeuerstein Is $gild curse truly real..?
12:01am
jq1234t @jq1234t
$GILD CD47: FDA put partial clinical hold on studies evaluating combination of magrolimab plus azacitidine includin… https://t.co/Evy2k8rsnG
12:01am
MarcJacksonLA @MarcJacksonLA
$GILD Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine… https://t.co/sjzF3Kizfd
12:01am
adamfeuerstein @adamfeuerstein
$GILD - FDA places partial clinical hold on studies combining magrolimab (its anti-CD47 antibody) with azicitadine,… https://t.co/2bWUbVjtMI
12:01am
StckPro @StckPro
$GILD NEW ARTICLE : Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Az… https://t.co/l9lPL5hxIk
12:01am
SFBusinessTimes @SFBusinessTimes
How $GILD could turn out to be a winner based on $SRRA's #cancer clinical trial success https://t.co/WKKmfQ00xv
12:01am
vtmtrading @vtmtrading
Gilead says FDA places partial clinical hold for studies on magrolimab combo $GILD
January 25th 2022, 11:01pm
otcdynamics @otcdynamics
$GILD Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine https://t.co/gW5CeTJWqN
January 25th 2022, 11:01pm
faststocknewss @faststocknewss
*GILEAD :PARTIAL CLINICAL HOLD FOR STUDIES EVALUATING MAGROLIMAB *GILEAD: STUDIES OUTSIDE OF COMBO W/ AZACITIDINE UNAFFECTED $GILD
January 25th 2022, 11:01pm
newsfilterio @newsfilterio
Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine $GILD https://t.co/qoQCLv64Rk
January 25th 2022, 11:01pm
StockNewsBot2 @StockNewsBot2
$GILD Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine https://t.co/tzUrGN4BpB
January 25th 2022, 11:01pm
stock_titan @stock_titan
$GILD Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine https://t.co/yER1PjxWlD
January 25th 2022, 11:01pm
bs_marker @bs_marker
Stock: $GILD - *** REALTIME TREND *** SELL BUY = 32.03% SELL = 67.97% Try now the Best Pivot Point Calculator!!… https://t.co/v4VSz3sBEE
January 25th 2022, 11:01pm
BioWino @BioWino
@saltadogato Will $gild buy in though?
January 25th 2022, 10:01pm
tradebotAI @tradebotAI
? Whale spotted! Someone just sold $78.33 million worth of $GILD
January 25th 2022, 10:01pm
TradeWithAlerts @TradeWithAlerts
Nice print for $GILD Size: 1137900 Price: 68.84 Amount: $78,333,036.00 Time: 1715 See more: https://t.co/5ljLbVxEd1… https://t.co/4kjPwJu4SL
January 25th 2022, 10:01pm
bio_clouseau @bio_clouseau
@bigpharmaguy Same reason as $GILD. $INCY anticipates difficulty enrolling confirmatory trials within a certain period
January 25th 2022, 10:01pm
bigpharmaguy @bigpharmaguy
@bio_clouseau this comes right after $GILD withdrew Zydelig as well.....
January 25th 2022, 9:01pm
dailycandlestix @dailycandlestix
$GILD Rising Price, Declining Volume Daily appearances since 2010: 70 Close 5 days later ±: Avg: -0.02 SD: 2.42 Wor… https://t.co/62pMeq3fBJ
January 25th 2022, 9:01pm
bs_marker @bs_marker
Stock: $GILD - Gilead Sciences *** NEWS *** Matinas BioPharma falls 17% amid pipeline, business updates for 2022 -… https://t.co/jUYBsSJwBA
January 25th 2022, 7:01pm
bs_marker @bs_marker
Stock: $GILD - *** REALTIME TREND *** SELL BUY = 27.73% SELL = 72.27% Try now the Best Pivot Point Calculator!!… https://t.co/bRvyTVT1Gm
January 25th 2022, 6:01pm
Persian1010 @Persian1010
$gild is someone interested in buying them?
January 25th 2022, 5:01pm
Sanctuary_Bio @Sanctuary_Bio
So given that $GILD BD has failed yet again, should we expect a disappointment from TROPiCS-02? https://t.co/Pm3U3q4fae
January 25th 2022, 5:01pm
Kevin_M_Biotech @Kevin_M_Biotech
@JacobPlieth @evaluatevantage Hope $glpg could do the same with filgo… $gild curse is real haha
January 25th 2022, 5:01pm
allincapital @allincapital
morons at $MRNA losing all that market cap without a deal. $GILD literally flat but since forever. https://t.co/R5Bd4J14cT
January 25th 2022, 4:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.